000 | 01311 a2200409 4500 | ||
---|---|---|---|
005 | 20250517164629.0 | ||
264 | 0 | _c20180710 | |
008 | 201807s 0 0 eng d | ||
022 | _a2284-0729 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYao, D-J | |
245 | 0 | 0 |
_aCorrelation between expression of LRP16, Ki67 and EGFR and breast cancer clinical pathologic factors and prognosis. _h[electronic resource] |
260 |
_bEuropean review for medical and pharmacological sciences _cJul 2017 |
||
300 |
_a47-51 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBreast Neoplasms _xmetabolism |
650 | 0 | 4 | _aCarboxylic Ester Hydrolases |
650 | 0 | 4 |
_aErbB Receptors _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aKi-67 Antigen _xmetabolism |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Proteins _xmetabolism |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aQiao, S | |
700 | 1 | _aZhang, Y | |
700 | 1 | _aZhao, Y-T | |
700 | 1 | _aYuan, C-H | |
773 | 0 |
_tEuropean review for medical and pharmacological sciences _gvol. 21 _gno. 3 Suppl _gp. 47-51 |
|
999 |
_c27404583 _d27404583 |